您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
TGF-β2 Protein, Human

TGF-β2 Protein, Human

货号: UA040293
价格: 1200
规格: 10μg
介绍: -
其他: -
产品规格
  • 物种

    Human
  • 分子别名

    BSC-1 cell growth inhibitor; cetermin; Glioblastoma-derived T-cell suppressor factor; G-TSF; MGC116892; polyergin; TGFB2; TGFbeta 2; TGF-beta 2; TGF-beta2; TGF-beta-2; transforming growth factor beta-2; transforming growth factor, beta 2.
  • Accession

    P61812
  • 浓度

    0.2mg/ml
  • 表达序列

    Ala303-Ser414
  • 表达宿主

    HEK293
  • 分子量

    12.7 kDa (monomer).

  • 纯度

    ≥95% by SDS-PAGE
  • 活性

    Measured by the(CAGA)12-luciferase reporter assay. The EC50 for this euect is 0.69ng/mL
  • 标记

    Unconjugated
  • 标签

    No Tag
  • 性状

    Liquid
  • 缓冲体系

    Dissolved in sterile 20 mM sodium citrate(pH=2.5) buuer . This solution can be diluted into other aqueous buuers. Centrifuge the vial prior to opening.
  • 储存条件

    Avoid repeated freeze-thaw cycles.
    It is recommended that the protein be aliquoted for optimal storage. 12 months from date of receipt, -20 to -70℃ as supplied

  • 稀释度

背景介绍
  • TGF-beta 2 (transforming growth factor beta 2) is one of three closely related mammalian members of the large TGF-beta superfamily that share a characteristic cysteine knot structure (1-7). TGF-beta 1, -2 and -3 are highly pleiotropic cytokines proposed to act as cellular switches that regulate processes such as immune function, proliferation and epithelial- mesenchymal transition (1-4). Each TGF-beta isoform has some non-redundant functions; for TGF-beta 2, mice with targeted deletion show defects in development of cardiac, lung, craniofacial, limb, eye, ear and urogenital systems (2).

    Human TGF-beta 2 cDNA encodes a 414 amino acid (aa) precursor that contains a 19 aa signal peptide and a 395 aa proprotein (8). A furin-like convertase processes the proprotein to generate an N-terminal 232 aa latency-associated peptide (LAP) and

    a C-terminal 112 aa mature TGF- beta 2 (8, 9). Disulfide-linked homodimers of LAP and TGF-beta 2 remain non-covalently associated after secretion, forming the small latent TGF-beta 1 complex (8-10). Covalent linkage of LAP to one of three latent TGF-beta binding proteins (LTBPs) creates a large latent complex that may interact with the extracellular matrix (9, 10).

    TGF-beta is activated from latency by pathways that include actions of the protease plasmin, matrix metalloproteases, thrombospondin 1 and a subset of integrins (10). Mature human TGF-beta 2 shows 100% aa identity with porcine, canine, equine and bovine TGF-beta 2, and 97% aa identity with mouse and rat TGF-beta 2. It demonstrates cross-species activity (1). TGF-beta 2 signaling begins with binding to a complex of the accessory receptor betaglycan (also known as TGF-beta RIII) and a type II ser/thr kinase receptor termed TGF-beta RII. This receptor then phosphorylates and activates another ser/thr kinase

    receptor, TGF-beta RI (also called activin receptor-like kinase (ALK) -5), or alternatively, ALK-1. The whole complex phosphorylates and activates Smad proteins that regulate transcription (3, 11, 12). Use of other signalin.

  • 生物活性JSON

    • Measured by (CAGA)12-luciferase reporter assay.

  • 电泳JSON

    • 4 ug/lane protein was resolved
      with SDS-PAGE under non-reducing (NR) and reducing (R)conditions and visualized by Coomassie blue staining.